Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses

Menglin Wang(University of North Carolina at Chapel Hill), Leaf Huang(University of North Carolina at Chapel Hill), Anne‐Sophie Hamy(Université Paris Cité), Juliane Nguyen(University of North Carolina at Chapel Hill), Fabien Reyal(Université Paris Sciences et Lettres), Oliver Artz(Memorial Sloan Kettering Cancer Center), Kuo‐Hsiung Lee(University of North Carolina at Chapel Hill), Benoı̂t Rousseau(Memorial Sloan Kettering Cancer Center), Jenny P.‐Y. Ting(University of North Carolina at Chapel Hill), Élise Dumas(Inserm), Kunyu Qiu(University of North Carolina at Chapel Hill), Philippe‐Jean Bousquet(Inserm), Yongqun He(University of Michigan), Yu Zhang(University of North Carolina at Chapel Hill), Yung‐Yi Cheng(China Medical University), Guannan Huang(University of North Carolina at Chapel Hill), Christine Le Bihan-Benjamin(Institut National du Cancer), Michael B. Foote(Memorial Sloan Kettering Cancer Center), Aaron C. Anselmo(University of North Carolina at Chapel Hill), Marc Hilmi(GERCOR (France)), Inès Khati(Institut National du Cancer), Hang Su(Albert Einstein College of Medicine), Paul M. Armistead(University of North Carolina at Chapel Hill), Jianfeng Guo(University of North Carolina at Chapel Hill), Ava M. Vargason(University of North Carolina at Chapel Hill), Janelle C. Arthur(University of North Carolina at Chapel Hill), Xuefei Zhou(University of North Carolina at Chapel Hill), Yun Liu(Weifang Medical University), Lin Lin(Zhengzhou University), Yue Sun(Imaging Center), Wantong Song(University of Science and Technology of China), Michael Z. Miao(University of North Carolina at Chapel Hill)
Nature Biotechnology
September 25, 2023
Cited by 192


Related Papers